HMS
CRMD icon

Hanseatic Management Services’s CorMedix CRMD Stock Holding History

Hanseatic Management Services’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$5.86K Buy
+724
New +$7.23K 0.01% 108

Other funds holding CRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FTM
First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hanseatic Management Services's CRMD Position: Q4 2024 in Review

Hanseatic Management Services opened a new position in CorMedix (CRMD) in Q4 2024: 724 shares worth $5.86K. The stake represents 0.01% of the portfolio and ranks #108 among its holdings.

129 funds tracked by Wall St. Rank hold CRMD as of Q4 2024.

  • Hanseatic Management Services held 724 shares of CorMedix worth $5.86K as of Q4 2024.
  • CorMedix was a new Hanseatic Management Services position in Q4 2024.
  • CorMedix made up 0.01% of Hanseatic Management Services's portfolio in Q4 2024, its #108 holding.
  • 129 funds tracked by Wall St. Rank held CorMedix as of Q4 2024.

Based on Hanseatic Management Services's 13F filing for Q4 2024, filed 15 Jan 2025.